Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.


The effects of daily treatment with GM1 ganglioside (30 mg/kg s.c.) from birth to day 30, on striatal pre- and postsynaptic markers of the dopaminergic system in euthyroid- and 32 day-old hypothyroid rats were studied. The purpose was to assess whether GM1 could prevent the extensive, hypothyroidism-provoked impairment of dopaminergic neurotransmission… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.